Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Low RiskFDA Drug
Medications & Supplements/Prescription Drugs

Benzphetamine and Benzonatate Recalled for Label Mix-Up

Agency Publication Date: May 26, 2022
Share:
Sign in to monitor this recall

Summary

Calvin Scott & Company, Inc. is recalling 23 bottles of Benzphetamine 50 mg tablets and Benzonatate 100 mg capsules because of a label mix-up. Bottles labeled as Benzonatate capsules actually contained Benzphetamine tablets, and bottles labeled as Benzphetamine tablets contained Benzonatate capsules. This error means patients could take a medication they were not prescribed, which could lead to adverse side effects or untreated medical conditions. If you believe you have the incorrect medication, contact your doctor or pharmacist immediately.

Risk

Taking the wrong medication can result in serious health risks, including receiving a controlled substance (Benzphetamine) instead of a cough suppressant (Benzonatate), or failing to receive intended treatment. No injuries or adverse incidents have been reported to date.

What You Should Do

  1. This recall affects 30-count bottles of Benzphetamine 50 mg tablets (NDC 10702-0040-50) and Benzonatate 100 mg capsules (NDC 67877-0573-05) distributed by Calvin Scott & Co., Inc.
  2. Check your prescription bottles for lot CS-20274-005 with expiration date 5/22 (Benzphetamine) or lot CS-20180W-004 with expiration date 3/22 (Benzonatate).
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) for additional questions.

Your Remedy Options

You have 2 options:

๐Ÿ’ฐOption 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
๐Ÿ—‘๏ธOption 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Benzphetamine tablets (30-count bottle)
Variants: 50mg, Tablets, CIII
Lot Numbers:
CS-20274-005 (Exp 5/22)
NDC:
10702-0040-50

Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123. Recall #: D-1123-2022.

Product: Benzonatate capsules (30-count bottle)
Variants: 100mg, Capsules
Lot Numbers:
CS-20180W-004 (Exp 3/22)
NDC:
67877-0573-05

Distributed by Calvin Scott & Co., Inc, Albuq., NM. 87123. Recall #: D-1124-2022.

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 90183
Status: Resolved
Manufacturer: Calvin Scott & Company, Inc.
Sold By: Physician in Alpharetta, GA
Manufactured In: United States
Units Affected: 2 products (13 bottles; 10 bottles)
Distributed To: Georgia
Agency Last Updated: June 9, 2022

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.